PHARMA LITERATI

Two batches of Johnson & Johnson’s popular baby shampoo have been found to be contaminated with formaldehyde. Drug inspectors in Rajasthan claim to have found a cancer-causing substance in the popular Johnson & Johnson ‘No More Tears’ baby shampoo, bringing yet another product of the US pharmaceutical giant under scrutiny over health concerns and reviving a controversy it claimed to have settled five years ago. According to a notice released by the Rajasthan drug controller Sunday, and sent to authorities across the country, two batches of the shampoo have been found to be contaminated with formaldehyde . Formaldehyde has been identified as a carcinogen, which is a substance that promotes the formation of cancer in the body. Both batches were manufactured at Johnson & Johnson’s facility at Baddi, Himachal Pradesh. “ We have found a higher amount [than stated by the company] of formaldehyde in J&J’s shampoos and the company has been informed about ...

Entire batch of Gahlot Institute of Pharmacy, Navi Mumbai participated in online GPAT test series 2019. 14 students who qualified GPAT were felicitated at an event recently.  All the credit to the faculty members of the institute  and the students who studies hard for the results. Pharma Literati was proud to be a step in this entire journey. All the best to the students in their career. 

The Union health and family welfare ministry has come out with Drugs and Cosmetics (Ninth Amendment) Rules, 2019 notifying implementation of new labelling norms for Schedule G, H, H1 and X drugs from April 1, 2019. As per the amended rules notified by the ministry on March 20, 2019, rule 97A shall be inserted in the Drugs and Cosmetics Rules, 1945, after rule 97 which reads “Notwithstanding anything contained in rules 96 and 97, the modified or additional requirements of labelling as may be specified in the notification of the government of India in the ministry of health and family welfare number G.S.R. 408(E), dated April 26, 2018, shall be on voluntary basis for a period commencing on the date of coming into force on this rule and ending on March 31, 2019, and thereafter shall be mandatory.”  Rule 97 of Drug & Cosmetics Act 1945 provides for printing caution/warning in respect of drugs covered under Schedule H, Schedule G and substance covered under the purview of Narcotic ...

A drug officer working for Punjab government's Food and Drugs Administration was shot dead in her office The woman, identified as Dr. Neha Shoree, was posted as the Zonal Licensing Officer with the Drug and Food Chemical Laboratory in Kharar, Mohali.  Police said that Dr. Shoree had raided Singh’s shop and cancelled his chemist shop licence, after recovery of some intoxicants.   As per reports, the accused, identified as Balwinder Singh, went to the FDA office on his motorbike around 10.30 AM. He then entered Dr. Neha Shoree’s office, shot her twice and shouted “Happy Holi”. The accused tried to run away after shooting Shoree, but was surrounded by people. Finding himself cornered, he took out the revolver and shot himself in chest and head. He succumbed to the injuries during treatment at hospital. Source: http://www.uniindia.com/chemist-shoots-drug-inspector-dead-commits-suicide/north/news/1544920.html

NIPER S.A.S. Nagar is offering summer training in the following ten departments below: 1. Medicinal Chemistry 2. Natural Products             • Traditional Medicine 3. Pharmaceutical Analysis 4. Pharmacology and Toxicology             • Regulatory Toxicology 5. Pharmaceutics 6. Biotechnology 7. Pharmacy Practice 8. Pharmaceutical Technology             • Pharm. Technology (Process Chemistry)             • Pharm. Technology (Biotechnology)             • Pharm. Technology (Formulations) 9. Pharmacoinformatics 10. Pharmaceutical Management Duration of training:                     ...

Pharma Literati is proud to be associated with Career counselling session at Gahlot Institute of Pharmacy, Navi Mumbai on 27th March 2019. Schedule: Topic Speaker Organization Time Career Opportunities in Pharmaceutical Industry  Dr. Amol Yelgaonkar Sr. General Manager (Head) – Corporate Quality and Regulatory Affairs, Themis Medicare Limited. 10.30 AM to 11.30 AM Opportunities in Pharmaceutical Equipment Sector  Mr Deepak Singh Head, R&D Sales, Gansons Ltd. 11.30 AM to 12.00 PM Higher studies after B. Pharm: Scope and opportunities Mr Vijaykumar Shivpuje Director, Patlex Business Solutions 12.00 PM to 12.30 PM

One of the earliest Indian drugmakers to have focused on innovative R&D, Glenmark Pharma is now spinning off its R&D business into a separate company that would be based in the US. Glenmark Pharma has hired a former executive from Gilead & Novartis to head the new company. All innovative molecules in the pipeline, including preclinical assets and technology, the R&D centres in Switzerland, Paramus, and Navi Mumbai, and the biologics manufacturing facility in Switzerland, along with 400 employees associated with innovative drug discovery will be part of the new company in the next six to nine months. Glenmark's current innovation pipeline consists of eight assets, including new chemical entities and new biologic entities in various stages of development. These are in the areas of immunology, oncology and pain management. But will the latest move enable Glenmark to succeed in its quest for discovering an innovative drug? Several of its peers, including ...

Multinational pharmaceutical companies are crying foul over the illegal import of innovator drugs worth crores of rupees into the Indian market from neighbouring countries and sale by pharmacies, distributors and websites. The Organisation of Pharmaceutical Producers of India, which represents Abbott, Pfizer, Novartis, Novo Nordisk, GSK, Bayer, Merck and Sanofi, among others, claims the rampant and unchecked import of innovator drugs was adversely affecting the revenue of India as well as the companies. “ We have noticed that the innovator drugs, mostly oncology (cancer) drugs, were being illegally imported into India through neighbouring countries like Bangladesh, Nepal, Bhutan and Sri Lanka ,” Kanchana TK, director general of OPPI, told  ET  in Hyderabad recently. However, it’s not clear if these drugs were originally produced for domestic consumption in those countries and were crossing the borders, she said. “ We are also not sure of the quality of these dru...

Thank you readers for 1000+ facebook likes for Pharma Literati's facebook Page.  Keep reading and sharing. https://www.facebook.com/Pharma-Literati-100508776966456/

Scores of pharmacists aspiring to join Maharashtra Forest Service have been left in lurch due to lackadaisical attitude of state forest department in ensuring that B Pharm becomes one of the eligibility criteria for state forest service examination conducted by Maharashtra Public Service Commission (MPSC). The state forest department has hardly paid heed to the matter despite direction from forest minister Sudhir Mungantiwar to take steps to incorporate B Pharm in education qualification of candidates appearing for Maharashtra forest service examination.  Mungantiwar issued direction last year following a representation by Maharashtra Registered Pharmacists Association (MRPA) in this regard.  MRPA president Kailash Tandale in the memorandum appealed to the state forest minister to make pharmacy graduates eligible for state forest service examination.  The minister assured Tandale that B Pharm qualification would be incorporated in the eligibility criteria f...

Pharma Literati blog was inactive for a while. We are back and would be coming with more opportunities for the pharmacy students.